Cytochrome P450 CYP3A in human renal cell cancer

British Journal of Cancer

Volumn 79, Issue 11-12, 1999, Pages 1836-1842

  Murray, G I ^a   McFadyen, M C E ^a   Mitchell, R T ^a   Cheung, Y L ^a   Kerr, A C ^a   Melvin, W T ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cytochrome P450; Kidney; Neoplasm

Indexed keywords

CYTOCHROME P450; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; KIDNEY PROXIMAL TUBULE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033042397     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690292     Document Type: Article

References (40)

1. Anttila S, Hukkanen J, Hakkola J, Stjernvall T, Beaune P, Edwards RJ, Boobis AR, Pelkonen O and Raunio H (1997) Expression and localization of CYP3A4 and CYPA5 in human lung. Am J Respir Cell Mol Biol 16: 242-249
2. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 72: 248-254
3. Capdevila J, Falck JR and Estabrook RW (1992) Cytochrome P450 and the arachidonate cascade. FASEB J 6: 731-736
4. Chang TKH, Weber GF, Crespi CL and Waxman DJ (1993) Differential activation of cyclophosphamide and ifosphamide by cytochrome P450 2B and cytochrome P450 3A in human liver-microsomes. Cancer Res 53: 5629-5637
5. Chapman AE and Goldstein LJ (1995) Multiple drug resistance; biologic basis and clinical significance in renal-cell carcinoma. Semin Oncol 22: 17-28
6. Fritz P, Behrle E, Beaune P, Eichelbaum M and Kroemer HK (1993) Differential expression of drug metabolising enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P450 3A and glutathione S-transferase. Histochemistry 99: 443-451
7. Gervot L, Carrière V, Costet P, Cugnene P-H, Berger A, Beaune PH and de Waziers I (1996) CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines. Environ Toxicol Pharmacol 2: 381-388
8. Gonzalez FJ and Gelboin HV (1994) Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 26: 165-183
9. Guengerich FP (1992) Metabolic activation of carcinogens. Pharmacol Ther 54: 17-62
10. Haehner BD, Gorski JC, Vandenbranden M, Wrighton SA, Janarden SK, Watkins PB and Hall SD (1996) Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 50: 52-59
11. Harris JW, Rahman A, Kim BR, Guengerich FP and Collins JM (1994) Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res 54: 4026-4035
12. Janardan SK, Lown KS, Schiedlinrern P, Thummel KE and Watkins PB (1996) Selective expression of CYP3A5 and not CYP3A4 in human blood. Pharmacogenetics 6: 379-385
13. Kawajiri K and Fujii-Kuriyama Y (1991) P450 and human cancer. Jpn J Cancer Res 82: 1325-1335
14. Kitada M and Kamataki T (1994) Cytochrome P450 in human fetal liver: significance and fetal specific expression. Drug Metab Dispos 26: 305-323
15. Kivistö KT, Kroemer HK and Eichelbaum M (1995a) The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 40: 523-530
16. Kivistö KT, Fritz P, Linder A, Friedel G, Beaune P and Kroemer HK (1995b) Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochem Cell Biol 103: 25-29
17. Kivistö KT, Griese E-U, Fritz P, Linder A, Hakkola J, Raunio H, Beaune P and Kroemer HK (1996) Expression of cytochrome P450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours. Arch Pharmacol 353: 207-212
18. Kovacs G, Akhtar M, Beckwith B, Gugert P, Cooper CS, Dleahunt B, Eble JN, Fleming S, Ljunberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Störkel S, Van Den Berg E and Zbar B (1997) The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133
19. McFadyen MCE, Melvin WT and Murray GI (1998) Regional distribution of individual forms of cytochrome P450 mRNA in normal human brain. Biochem Pharmacol 55: 825-830
20. McKay JA, Weaver RJ, Murray GI, Ewen SWB, Melvin WT and Burke MD (1995) Expression of microsomal epoxide hydrolase in normal and neoplastic human kidney. J Histochem Cytochem 43: 615-620
21. McKinnon RA, Burgess WM, Hall Pdela M, Roberts-Thomson SJ, Gonzalez FJ and McManus ME (1995) Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 36: 259-267
22. Massaad L, de Waziers I, Ribrag V, Janot F, Beaune PH, Morizet J, Gouyette A and Chabot GG (1992) Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res 52: 6567-6575
23. Motzer RJ, Bander NH and Nanus DM (1996) Renal cell carcinoma. N Engl J Med 335: 865-875
24. Murray GI, Barnes TS, Sewell HF, Ewen SWB, Melvin WT, Shaw PM, Fowler J and Burke MD (1987) Cytochrome P450 localisation in normal human adult and foetal liver by immunocytochemistry using a monoclonal antibody against human cytochrome P450. Histochem J 19: 537-545
25. Murray GI, Barnes TS, Sewell HF, Ewen SWB, Melvin WT and Burke MD (1988) The immunocytochemical localisation and distribution of cytochrome P450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P450. Br J Clin Pharmacol 25: 465-475
26. Murray GI, Weaver RJ, Paterson PJ, Ewen SWB, Melvin WT and Burke M (1993) Expression of xenobiotic metabolising enzymes in breast cancer. J Pathol 169: 347-353
27. Murray GI, Pritchard S, Melvin WT and Burke MD (1995) Cytochrome P450 CYP3A5 in the human anterior pituitary gland. FEBS Letts 364: 79-82
28. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD and Melvin WT (1997) Tumour specific expression of cytochrome P450 CYP1B1. Cancer Res 57: 3026-3031
29. Murray GI, Taylor MC, Burke MD and Melvin WT (1998) Enhanced expression of cytochrome P450 in stomach cancer. Br J Cancer 77: 1040-1044
30. Nebert DW (1994) Drug-metabolizing-enzymes in ligand-modulated transcription. Biochem Pharmacol 47: 25-37
31. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon JM, Estabrook RW, Gunsalus IC, and Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6: 1-42
32. Patterson LH (1993) Rationale for the use of N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive drugs. Cancer Metast Rev 12: 119-234
33. Roberts-Thomson SJ, McManus ME, Tukey RH, Gonzalez FJ and Holder GM (1995) Metabolism of polycyclic aza-aromatic carcinogens catalyzed by four expressed human cytochromes P450, Cancer Res 55: 1052-1059
34. Sarabia SF, Zhu BT, Kurosawa T, Tohma M and Liehr JG (1997) Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens. Chem Res Toxicol 10: 767-771
35. Schuetz EG, Schuetz JD, Grogan WM, Naray-Fejes-Toth A, Fejes-Toth G, Raucy J, Guzelian P, Gionela K and Watlington CO (1992) Expression of cytochrome P450 3A in amphibian, rat, and human kidney. Arch Biochem Biophys 294: 206-214
36. Schuetz JD, Beach DL and Guzelian PS (1994) Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4: 11-20
37. Shaw PM, Barnes TS, Cameron D, Engeset J, Melvin WT, Omar G, Petrie JC, Rush WR, Snyder CP, Whiting PH and Burke MD (1989) Purification and characterization of an anticonvulsant-induced human cytochrome P450 catalysing cyclosporin metabolism. Biochem J 262: 653-663
38. Stadler W and Vogelzang NJ (1993) Human renal cancer carcinogenesis; a review of recent advances. Annal Oncol 4: 451-462
39. Walker D, Flinois JP, Monkman SC, Beloc C, Boddy AV, Cholerton S, Daly AK, Lind MJ, Pearson ADJ, Beaune PH and Idle JR (1994) Identification of the major human hepatic cytochrome P450 involved in activation and n-dechloroethylation of ifosfamide. Biochem Pharmacol 47: 1157-1160
40. Yagoda A, Abi-Rached B and Petrylak D (1995) Chemotherapy for advanced renal cell carcinoma. Semin Oncol 22: 42-60